MIR vs NVST vs OSIS vs XRAY

For growth investors, OSI Systems, Inc.

(OSIS) is the stronger pick with 11. 3% revenue growth year-over-year, versus -3. 0% for DENTSPLY SIRONA Inc. (XRAY). OSI Systems, Inc. (OSIS) offers the better valuation at 27. 7x trailing P/E (23. 0x forward), making it the more compelling value choice. Analysts rate Mirion Technologies, Inc. (MIR) a "Buy" — based on 8 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, OSI Systems, Inc.

(OSIS) is the cheapest at 27. 7x versus Mirion Technologies, Inc. at 179. 5x. On forward P/E, DENTSPLY SIRONA Inc. is actually cheaper at 7. 7x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: OSI Systems, Inc. wins at 1. 39x versus Envista Holdings Corp's 11. 53x — a reasonable growth-adjusted valuation.

Over the past 5 years, OSI Systems, Inc.

(OSIS) delivered a total return of +149. 9%, compared to -80. 1% for DENTSPLY SIRONA Inc. (XRAY). Over 10 years, the gap is even starker: OSIS returned +372. 9% versus XRAY's -74. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), OSI Systems, Inc.

(OSIS) is the lower-risk stock at 1. 44β versus Mirion Technologies, Inc. 's 1. 98β — meaning MIR is approximately 37% more volatile than OSIS relative to the S&P 500. On balance sheet safety, Envista Holdings Corp (NVST) carries a lower debt/equity ratio of 55% versus 184% for DENTSPLY SIRONA Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), OSI Systems, Inc.

(OSIS) is pulling ahead at 11. 3% versus -3. 0% for DENTSPLY SIRONA Inc. (XRAY). On earnings-per-share growth, the picture is similar: Mirion Technologies, Inc. grew EPS 161. 1% year-over-year, compared to 18. 0% for OSI Systems, Inc.. Over a 3-year CAGR, OSIS leads at 13. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

OSI Systems, Inc.

(OSIS) is the more profitable company, earning 8. 7% net margin versus -16. 3% for DENTSPLY SIRONA Inc. — meaning it keeps 8. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: OSIS leads at 12. 7% versus 5. 6% for MIR. At the gross margin level — before operating expenses — NVST leads at 55. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, OSI Systems, Inc. (OSIS) is the more undervalued stock at a PEG of 1. 39x versus Envista Holdings Corp's 11. 53x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, DENTSPLY SIRONA Inc. (XRAY) trades at 7. 7x forward P/E versus 36. 2x for Mirion Technologies, Inc. — 28. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MIR: 44. 3% to $28. 50.

In this comparison, XRAY (5.

9% yield) pays a dividend. MIR, NVST, OSIS do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, OSI Systems, Inc.

(OSIS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+372. 9% 10Y return). Mirion Technologies, Inc. (MIR) carries a higher beta of 1. 98 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (OSIS: +372. 9%, MIR: +98. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (MIR (Industrials) and NVST (Healthcare) and OSIS (Technology) and XRAY (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: MIR is a small-cap quality compounder stock; NVST is a small-cap quality compounder stock; OSIS is a small-cap quality compounder stock; XRAY is a small-cap income-oriented stock. XRAY pays a dividend while MIR, NVST, OSIS do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.